John Umstead V

CFO at G1 Therapeutics

Mr. Umstead joined G1 in 2018. In his role as Chief Financial Officer, he is responsible for the financial operations of the company, including SEC reporting, financial planning and analysis, and treasury. Since joining, Mr. Umstead has provided counsel on the company’s SEC filings, financings, license agreements, and implementation and effectiveness of financial controls and systems following commercial launch.

Previously, Mr. Umstead was with PricewaterhouseCoopers LLP, where he worked in the audit and assurance practice primarily serving large publicly traded corporations, and later moved into the Capital Markets Accounting and Advisory Services group where he advised public and private companies in complex accounting and financial reporting matters related to business combinations, debt and equity financings, divestitures, and other areas involving technical accounting. Before joining PricewaterhouseCoopers LLP, Mr. Umstead spent 5 years in commercial banking.

Mr. Umstead received his Master of Accounting from the Kenan-Flagler Business School at the University of North Carolina at Chapel Hill and his B.A. in Political Science from the University of North Carolina at Chapel Hill, and is a certified public accountant in the State of North Carolina.

Timeline

  • CFO

    Current role